IMPFSTOFFE GEGEN OVARIALKARZINOM

European patent · EP3785729 · In force

Register entry

Publication number
EP3785729
Application number
EP20182156
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Sep 2, 2016
Published
Mar 3, 2021
Granted
Mar 13, 2024
Protection ends at the latest
Sep 1, 2036
Next annual fee due
Sep 30, 2027
IPC classes
A61K 39/00 (2006.01)
A61K 31/337 (2006.01)
A61K 31/704 (2006.01)
A61K 45/06 (2006.01)
Priority
US 201562213286 P 02.09.2015
Divided from
EP16843091
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Oct 1, 2026

    Next annual fee due on

    Next annual fee due on
    30.09.2026 → 30.09.2027

    Published in Swissreg on 01.10.2026

  2. Oct 1, 2025

    Next annual fee due on

    Next annual fee due on
    30.09.2025 → 30.09.2026

    Published in Swissreg on 01.10.2025

  3. Jan 22, 2025

    Change

    Published in Swissreg on 22.01.2025

  4. Oct 3, 2024

    Change

    Published in Swissreg on 03.10.2024

  5. May 14, 2024

    Agent entered

    Representative
    HGF GmbH, OBC Suisse AG, Aeschengraben 29, 4051 Basel

    Published in Swissreg on 14.05.2024

  6. Mar 13, 2024

    Granted

    Published in Swissreg on 13.03.2024

Parties

Holder

The Cleveland Clinic Foundation

9500 Euclid Avenue, Cleveland, OH 44195, US

Agent

HGF GmbH

HGF GmbH OBC Suisse AG

Aeschengraben 29, 4051 Basel

Inventor

JOHNSON, Justin, M.

Willoughby Hills, OH 44902, US

TUOHY, Vincent, K.

Broadview Heights, OH 44147, US

MAZUMDER, Suparna

Olmsted Fallas, OH 44138, US

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.